<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">curcumin </span>
   <span class="font21">migraine </span>
   <span class="font21">naproxen </span>
   <span class="font20">(.) </span>
   <span class="font19">mg/. </span>
   <span class="font19">liposomal </span>
   <span class="font18">oxidative </span>
   <span class="font18">solution </span>
   <span class="font18">group </span>
   <span class="font17">compared </span>
   <span class="font16">rat </span>
   <span class="font16">stress </span>
   <span class="font16">model </span>
   <span class="font16">effect </span>
   <span class="font16">mg/kg) </span>
   <span class="font16">pretreated </span>
   <span class="font15">Curcumin </span>
   <span class="font15">antioxidant </span>
   <span class="font15">treatment </span>
   <span class="font15">(n=), </span>
   <span class="font14">formalin </span>
   <span class="font14">kg) </span>
   <span class="font14">{border-style </span>
   <span class="font14">pain </span>
   <span class="font14">total </span>
   <span class="font13">Table </span>
   <span class="font13">phase </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">()) </span>
   <span class="font13">MNPCC </span>
   <span class="font13">combined </span>
   <span class="font13">experimental </span>
   <span class="font13">increased </span>
   <span class="font13">including </span>
   <span class="font13">increase </span>
   <span class="font13">rats </span>
   <span class="font13">study </span>
   <span class="font12">MNPCCl </span>
   <span class="font12">Pain </span>
   <span class="font12">central </span>
   <span class="font12">concentration </span>
   <span class="font12">induced </span>
   <span class="font12">inflammatory </span>
   <span class="font12">significant </span>
   <span class="font12">acute </span>
   <span class="font12">associated </span>
   <span class="font12">nitroglycerin </span>
   <span class="font12">Res </span>
   <span class="font12">groups </span>
   <span class="font12">inflammation </span>
   <span class="font12">previously </span>
   <span class="font12">(n=) </span>
   <span class="font12">administration </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">effects </span>
   <span class="font12">lipid </span>
   <span class="font12">nociception </span>
   <span class="font12">oxide </span>
   <span class="font12">response </span>
   <span class="font12">second </span>
   <span class="font12">showed </span>
   <span class="font12">test </span>
   <span class="font12">thiol </span>
   <span class="font11">Figure </span>
   <span class="font11">Pharmacol </span>
   <span class="font11">capacity </span>
   <span class="font11">control </span>
   <span class="font11">mechanism </span>
   <span class="font11">nanoparticles </span>
   <span class="font11">reduced </span>
   <span class="font11">shown </span>
   <span class="font11">significantly </span>
   <span class="font11">using </span>
   <span class="font11">(): </span>
   <span class="font11">(MNPCCl </span>
   <span class="font11">MNP: </span>
   <span class="font11">activity </span>
   <span class="font11">analgesic </span>
   <span class="font11">blood </span>
   <span class="font11">combination </span>
   <span class="font11">curcumin, </span>
   <span class="font11">hyperalgesia </span>
   <span class="font11">injection </span>
   <span class="font11">intraperitoneal </span>
   <span class="font11">nitric </span>
   <span class="font11">parameters </span>
   <span class="font11">production </span>
   <span class="font11">px; </span>
   <span class="font11">release </span>
   <span class="font11">use </span>
   <span class="font11">{font-family </span>
   <span class="font11">Med </span>
   <span class="font11">attacks </span>
   <span class="font11">efficacy </span>
   <span class="font11">font-size </span>
   <span class="font11">i.p. </span>
   <span class="font11">level </span>
   <span class="font11">migraine: </span>
   <span class="font11">number </span>
   <span class="font11">reducing </span>
   <span class="font11">serotonin </span>
   <span class="font11">synthesis </span>
   <span class="font11">therapeutic </span>
   <span class="font11">()/() </span>
   <span class="font11">(n=). </span>
   <span class="font11">Bulboacă </span>
   <span class="font11">Headache </span>
   <span class="font11">MDA </span>
   <span class="font11">MNP </span>
   <span class="font11">Naproxen </span>
   <span class="font11">Neurol </span>
   <span class="font11">Sci </span>
   <span class="font11">[], </span>
   <span class="font11">acid </span>
   <span class="font11">cerebral </span>
   <span class="font11">curcumin-loaded </span>
   <span class="font11">described </span>
   <span class="font11">double; </span>
   <span class="font11">expression </span>
   <span class="font11">findings </span>
   <span class="font11">flinches </span>
   <span class="font11">following </span>
   <span class="font11">i.v. </span>
   <span class="font11">inhibition </span>
   <span class="font11">injury </span>
   <span class="font11">mechanisms </span>
   <span class="font11">migraine, </span>
   <span class="font11">migraine. </span>
   <span class="font11">nociceptive </span>
   <span class="font11">rapid </span>
   <span class="font11">reported </span>
   <span class="font11">respectively </span>
   <span class="font11">role </span>
   <span class="font11">sensitization </span>
   <span class="font11">solid </span>
   <span class="font11">status </span>
   <span class="font11">studies </span>
   <span class="font11">therapy </span>
   <span class="font11">trigeminal </span>
   <span class="font11">used </span>
   <span class="font11">CCl </span>
   <span class="font11">Eur </span>
   <span class="font11">M-C </span>
   <span class="font11">NO, </span>
   <span class="font11">NPCC </span>
   <span class="font11">NSAIDs </span>
   <span class="font11">Wang </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cell </span>
   <span class="font11">chronic </span>
   <span class="font11">contribute </span>
   <span class="font11">cortical </span>
   <span class="font11">intensity </span>
   <span class="font11">intravenous </span>
   <span class="font11">kg). </span>
   <span class="font11">levels </span>
   <span class="font11">measured </span>
   <span class="font11">nitroglycerin-induced </span>
   <span class="font11">oxygen </span>
   <span class="font11">patients </span>
   <span class="font11">plasma </span>
   <span class="font11">potential </span>
   <span class="font11">pretreatment </span>
   <span class="font11">prostaglandin </span>
   <span class="font11">receptor </span>
   <span class="font11">reduce </span>
   <span class="font11">result </span>
   <span class="font11">shakes </span>
   <span class="font11">solid; </span>
   <span class="font11">untreated </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(M-C) </span>
   <span class="font10">(P&amp;lt;.). </span>
   <span class="font10">Bolboacă </span>
   <span class="font10">Clin </span>
   <span class="font10">Drug </span>
   <span class="font10">Group </span>
   <span class="font10">However, </span>
   <span class="font10">MDA, </span>
   <span class="font10">Migraine </span>
   <span class="font10">Oxidative </span>
   <span class="font10">Study </span>
   <span class="font10">TNF-α </span>
   <span class="font10">Ther </span>
   <span class="font10">activation </span>
   <span class="font10">animals </span>
   <span class="font10">arachidonic </span>
   <span class="font10">biomarkers </span>
   <span class="font10">bold </span>
   <span class="font10">cause </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">decrease </span>
   <span class="font10">decreased </span>
   <span class="font10">em; </span>
   <span class="font10">enhanced </span>
   <span class="font10">formulation </span>
   <span class="font10">higher </span>
   <span class="font10">include </span>
   <span class="font10">liposomes </span>
   <span class="font10">low </span>
   <span class="font10">malondialdehyde </span>
   <span class="font10">mast </span>
   <span class="font10">method </span>
   <span class="font10">mice </span>
   <span class="font10">migraine; </span>
   <span class="font10">molecules </span>
   <span class="font10">naproxen, </span>
   <span class="font10">necrosis </span>
   <span class="font10">nervous </span>
   <span class="font10">neurons </span>
   <span class="font10">neuropathic </span>
   <span class="font10">peptide </span>
   <span class="font10">phase) </span>
   <span class="font10">present </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">ratio </span>
   <span class="font10">reactive </span>
   <span class="font10">represent </span>
   <span class="font10">represents </span>
   <span class="font10">review </span>
   <span class="font10">size </span>
   <span class="font10">spreading </span>
   <span class="font10">status, </span>
   <span class="font10">stress, </span>
   <span class="font10">test, </span>
   <span class="font10">treated </span>
   <span class="font10">treatments </span>
   <span class="font10">tumor </span>
  </p>
 </body>
</html>
